{'fraction_non_alphanumeric': 0.015296367112810707, 'fraction_numerical': 0.036328871892925434, 'mean_word_length': 5.158823529411765, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Benefits of a dedicated cystic fibrosis pharmacist.

The Manchester Adult Cystic Fibrosis Centre (MACFC) moved in 1994 from North Manchester Hospital to a purpose-built facility at Wythenshawe Hospital with 140 adult patients with cystic fibrosis (CF). By 2003 there were 250 patients attending the MACFC. As the life expectancy of CF patients increases so does the complexity of their disease and their medication regimens. The complexity and cost of such regimens demand a major pharmaceutical care input for these patients. Prior to 2001 pharmacy services were delivered to the MACFC through a traditional organization based in a central pharmacy which also provided pharmacy services to 39 wards, 700 beds, 57 498 inpatient admissions and 251 246 consultant-led outpatient attendance appointments each year. In 2001 a dedicated CF pharmacist was appointed as part of the multidisciplinary team. The CF pharmacist is located in the MACFC and responsible operationally to the CF Clinical Director and professionally to the Director of Pharmacy.